Marathon Pharmaceuticals, LLC Prepares For Launch Of New Rare Disease Treatments By Selling Non-Strategic Products To Valeant (VRX) Including Isuprel And Nitropress
Research and Markets: China Sleep Disorder Treatment Drugs Markets Report 2015